nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP2C19—Memantine—Alzheimer's disease	0.106	0.383	CbGbCtD
Bromazepam—CYP3A4—Rivastigmine—Alzheimer's disease	0.074	0.267	CbGbCtD
Bromazepam—CYP3A4—Donepezil—Alzheimer's disease	0.0591	0.213	CbGbCtD
Bromazepam—CYP3A4—Galantamine—Alzheimer's disease	0.0381	0.137	CbGbCtD
Bromazepam—Incontinence—Galantamine—Alzheimer's disease	0.0132	0.0387	CcSEcCtD
Bromazepam—Hostility—Donepezil—Alzheimer's disease	0.00647	0.0189	CcSEcCtD
Bromazepam—Multiple fractures—Donepezil—Alzheimer's disease	0.00616	0.018	CcSEcCtD
Bromazepam—Fracture—Donepezil—Alzheimer's disease	0.00616	0.018	CcSEcCtD
Bromazepam—Fracture—Memantine—Alzheimer's disease	0.00559	0.0164	CcSEcCtD
Bromazepam—Multiple fractures—Memantine—Alzheimer's disease	0.00559	0.0164	CcSEcCtD
Bromazepam—Fracture—Rivastigmine—Alzheimer's disease	0.00547	0.016	CcSEcCtD
Bromazepam—Multiple fractures—Rivastigmine—Alzheimer's disease	0.00547	0.016	CcSEcCtD
Bromazepam—Aggression—Galantamine—Alzheimer's disease	0.00526	0.0154	CcSEcCtD
Bromazepam—Delusion—Donepezil—Alzheimer's disease	0.00506	0.0148	CcSEcCtD
Bromazepam—GABRQ—forebrain—Alzheimer's disease	0.0048	0.0293	CbGeAlD
Bromazepam—Delusion—Memantine—Alzheimer's disease	0.00459	0.0134	CcSEcCtD
Bromazepam—Delusion—Rivastigmine—Alzheimer's disease	0.00449	0.0132	CcSEcCtD
Bromazepam—Nightmare—Galantamine—Alzheimer's disease	0.00446	0.0131	CcSEcCtD
Bromazepam—GABRQ—telencephalon—Alzheimer's disease	0.00441	0.0269	CbGeAlD
Bromazepam—Aggression—Donepezil—Alzheimer's disease	0.00407	0.0119	CcSEcCtD
Bromazepam—GABRR1—forebrain—Alzheimer's disease	0.004	0.0244	CbGeAlD
Bromazepam—Speech disorder—Memantine—Alzheimer's disease	0.00378	0.0111	CcSEcCtD
Bromazepam—Aggression—Memantine—Alzheimer's disease	0.0037	0.0108	CcSEcCtD
Bromazepam—Speech disorder—Rivastigmine—Alzheimer's disease	0.0037	0.0108	CcSEcCtD
Bromazepam—Aggression—Rivastigmine—Alzheimer's disease	0.00362	0.0106	CcSEcCtD
Bromazepam—GABRD—forebrain—Alzheimer's disease	0.00348	0.0212	CbGeAlD
Bromazepam—Cardiac failure—Galantamine—Alzheimer's disease	0.00344	0.0101	CcSEcCtD
Bromazepam—GABRG1—forebrain—Alzheimer's disease	0.00335	0.0205	CbGeAlD
Bromazepam—GABRA5—forebrain—Alzheimer's disease	0.00323	0.0197	CbGeAlD
Bromazepam—GABRD—telencephalon—Alzheimer's disease	0.0032	0.0195	CbGeAlD
Bromazepam—Ataxia—Galantamine—Alzheimer's disease	0.00315	0.00923	CcSEcCtD
Bromazepam—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00314	0.00919	CcSEcCtD
Bromazepam—Nightmare—Memantine—Alzheimer's disease	0.00314	0.00919	CcSEcCtD
Bromazepam—GABRG1—telencephalon—Alzheimer's disease	0.00308	0.0188	CbGeAlD
Bromazepam—Euphoric mood—Donepezil—Alzheimer's disease	0.00308	0.00901	CcSEcCtD
Bromazepam—Nightmare—Rivastigmine—Alzheimer's disease	0.00307	0.00899	CcSEcCtD
Bromazepam—GABRA6—telencephalon—Alzheimer's disease	0.00306	0.0187	CbGeAlD
Bromazepam—GABRB1—telencephalon—Alzheimer's disease	0.00299	0.0182	CbGeAlD
Bromazepam—GABRA5—telencephalon—Alzheimer's disease	0.00297	0.0181	CbGeAlD
Bromazepam—Muscular weakness—Galantamine—Alzheimer's disease	0.00296	0.00866	CcSEcCtD
Bromazepam—GABRA4—forebrain—Alzheimer's disease	0.00293	0.0179	CbGeAlD
Bromazepam—Sleep disorder—Memantine—Alzheimer's disease	0.00273	0.00798	CcSEcCtD
Bromazepam—GABRA4—telencephalon—Alzheimer's disease	0.0027	0.0165	CbGeAlD
Bromazepam—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00267	0.00781	CcSEcCtD
Bromazepam—Cardiac failure—Donepezil—Alzheimer's disease	0.00266	0.0078	CcSEcCtD
Bromazepam—GABRR3—nervous system—Alzheimer's disease	0.0026	0.0159	CbGeAlD
Bromazepam—GABRQ—nervous system—Alzheimer's disease	0.0026	0.0159	CbGeAlD
Bromazepam—Psychotic disorder—Donepezil—Alzheimer's disease	0.00254	0.00743	CcSEcCtD
Bromazepam—GABRQ—central nervous system—Alzheimer's disease	0.00251	0.0153	CbGeAlD
Bromazepam—Irritability—Donepezil—Alzheimer's disease	0.00248	0.00726	CcSEcCtD
Bromazepam—GABRB2—forebrain—Alzheimer's disease	0.00245	0.015	CbGeAlD
Bromazepam—GABRG2—forebrain—Alzheimer's disease	0.00245	0.015	CbGeAlD
Bromazepam—Ataxia—Donepezil—Alzheimer's disease	0.00244	0.00715	CcSEcCtD
Bromazepam—Cardiac failure—Memantine—Alzheimer's disease	0.00242	0.00708	CcSEcCtD
Bromazepam—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00237	0.00692	CcSEcCtD
Bromazepam—Diplopia—Memantine—Alzheimer's disease	0.00236	0.00691	CcSEcCtD
Bromazepam—Diplopia—Rivastigmine—Alzheimer's disease	0.00231	0.00676	CcSEcCtD
Bromazepam—Hallucination—Galantamine—Alzheimer's disease	0.00231	0.00676	CcSEcCtD
Bromazepam—Psychotic disorder—Memantine—Alzheimer's disease	0.0023	0.00675	CcSEcCtD
Bromazepam—Muscular weakness—Donepezil—Alzheimer's disease	0.00229	0.00671	CcSEcCtD
Bromazepam—GABRG3—nervous system—Alzheimer's disease	0.00228	0.0139	CbGeAlD
Bromazepam—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00228	0.00667	CcSEcCtD
Bromazepam—GABRR2—nervous system—Alzheimer's disease	0.00226	0.0138	CbGeAlD
Bromazepam—GABRG2—telencephalon—Alzheimer's disease	0.00225	0.0138	CbGeAlD
Bromazepam—GABRB2—telencephalon—Alzheimer's disease	0.00225	0.0138	CbGeAlD
Bromazepam—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00225	0.0066	CcSEcCtD
Bromazepam—Irritability—Memantine—Alzheimer's disease	0.00225	0.00659	CcSEcCtD
Bromazepam—Cardiac arrest—Memantine—Alzheimer's disease	0.00224	0.00657	CcSEcCtD
Bromazepam—GABRA2—forebrain—Alzheimer's disease	0.00224	0.0137	CbGeAlD
Bromazepam—Ataxia—Memantine—Alzheimer's disease	0.00222	0.0065	CcSEcCtD
Bromazepam—GABRG3—central nervous system—Alzheimer's disease	0.0022	0.0134	CbGeAlD
Bromazepam—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00219	0.00643	CcSEcCtD
Bromazepam—GABRR1—nervous system—Alzheimer's disease	0.00217	0.0133	CbGeAlD
Bromazepam—Ataxia—Rivastigmine—Alzheimer's disease	0.00217	0.00635	CcSEcCtD
Bromazepam—Eye disorder—Galantamine—Alzheimer's disease	0.00217	0.00635	CcSEcCtD
Bromazepam—GABRA1—forebrain—Alzheimer's disease	0.00216	0.0132	CbGeAlD
Bromazepam—Cardiac disorder—Galantamine—Alzheimer's disease	0.00215	0.0063	CcSEcCtD
Bromazepam—GABRR2—cerebellum—Alzheimer's disease	0.00213	0.013	CbGeAlD
Bromazepam—GABRR1—central nervous system—Alzheimer's disease	0.00209	0.0128	CbGeAlD
Bromazepam—Muscular weakness—Memantine—Alzheimer's disease	0.00208	0.00609	CcSEcCtD
Bromazepam—GABRA2—telencephalon—Alzheimer's disease	0.00206	0.0126	CbGeAlD
Bromazepam—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00204	0.00596	CcSEcCtD
Bromazepam—Mental disorder—Galantamine—Alzheimer's disease	0.00203	0.00595	CcSEcCtD
Bromazepam—Malnutrition—Galantamine—Alzheimer's disease	0.00202	0.00591	CcSEcCtD
Bromazepam—GABRQ—brain—Alzheimer's disease	0.00199	0.0122	CbGeAlD
Bromazepam—GABRA1—telencephalon—Alzheimer's disease	0.00199	0.0122	CbGeAlD
Bromazepam—Tension—Galantamine—Alzheimer's disease	0.00198	0.0058	CcSEcCtD
Bromazepam—Nervousness—Galantamine—Alzheimer's disease	0.00196	0.00574	CcSEcCtD
Bromazepam—Muscle spasms—Galantamine—Alzheimer's disease	0.00194	0.00568	CcSEcCtD
Bromazepam—Vision blurred—Galantamine—Alzheimer's disease	0.0019	0.00557	CcSEcCtD
Bromazepam—Tremor—Galantamine—Alzheimer's disease	0.00189	0.00554	CcSEcCtD
Bromazepam—GABRD—nervous system—Alzheimer's disease	0.00189	0.0115	CbGeAlD
Bromazepam—GABRB3—forebrain—Alzheimer's disease	0.00188	0.0115	CbGeAlD
Bromazepam—Agitation—Galantamine—Alzheimer's disease	0.00186	0.00543	CcSEcCtD
Bromazepam—GABRD—central nervous system—Alzheimer's disease	0.00182	0.0111	CbGeAlD
Bromazepam—GABRG1—nervous system—Alzheimer's disease	0.00182	0.0111	CbGeAlD
Bromazepam—GABRA6—nervous system—Alzheimer's disease	0.00181	0.011	CbGeAlD
Bromazepam—Hallucination—Donepezil—Alzheimer's disease	0.00179	0.00524	CcSEcCtD
Bromazepam—Palpitations—Galantamine—Alzheimer's disease	0.00178	0.00522	CcSEcCtD
Bromazepam—Drowsiness—Rivastigmine—Alzheimer's disease	0.00178	0.00521	CcSEcCtD
Bromazepam—GABRD—cerebellum—Alzheimer's disease	0.00178	0.0109	CbGeAlD
Bromazepam—GABRB1—nervous system—Alzheimer's disease	0.00176	0.0108	CbGeAlD
Bromazepam—GABRA5—nervous system—Alzheimer's disease	0.00175	0.0107	CbGeAlD
Bromazepam—GABRG1—central nervous system—Alzheimer's disease	0.00175	0.0107	CbGeAlD
Bromazepam—Convulsion—Galantamine—Alzheimer's disease	0.00175	0.00512	CcSEcCtD
Bromazepam—GABRG3—brain—Alzheimer's disease	0.00174	0.0106	CbGeAlD
Bromazepam—GABRA6—central nervous system—Alzheimer's disease	0.00174	0.0106	CbGeAlD
Bromazepam—GABRB3—telencephalon—Alzheimer's disease	0.00173	0.0106	CbGeAlD
Bromazepam—GABRG1—cerebellum—Alzheimer's disease	0.00171	0.0104	CbGeAlD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00171	0.005	CcSEcCtD
Bromazepam—GABRA6—cerebellum—Alzheimer's disease	0.0017	0.0104	CbGeAlD
Bromazepam—GABRB1—central nervous system—Alzheimer's disease	0.0017	0.0104	CbGeAlD
Bromazepam—GABRA5—central nervous system—Alzheimer's disease	0.00169	0.0103	CbGeAlD
Bromazepam—Dry mouth—Galantamine—Alzheimer's disease	0.00168	0.00492	CcSEcCtD
Bromazepam—Confusional state—Galantamine—Alzheimer's disease	0.00166	0.00487	CcSEcCtD
Bromazepam—GABRR1—brain—Alzheimer's disease	0.00166	0.0101	CbGeAlD
Bromazepam—GABRB1—cerebellum—Alzheimer's disease	0.00166	0.0101	CbGeAlD
Bromazepam—GABRA3—nervous system—Alzheimer's disease	0.00163	0.00997	CbGeAlD
Bromazepam—Hallucination—Memantine—Alzheimer's disease	0.00162	0.00476	CcSEcCtD
Bromazepam—Nervous system disorder—Galantamine—Alzheimer's disease	0.00162	0.00473	CcSEcCtD
Bromazepam—Tachycardia—Galantamine—Alzheimer's disease	0.00161	0.00471	CcSEcCtD
Bromazepam—Connective tissue disorder—Memantine—Alzheimer's disease	0.0016	0.0047	CcSEcCtD
Bromazepam—Skin disorder—Galantamine—Alzheimer's disease	0.0016	0.00469	CcSEcCtD
Bromazepam—GABRA4—nervous system—Alzheimer's disease	0.00159	0.00971	CbGeAlD
Bromazepam—Hallucination—Rivastigmine—Alzheimer's disease	0.00159	0.00465	CcSEcCtD
Bromazepam—Mental disorder—Donepezil—Alzheimer's disease	0.00158	0.00461	CcSEcCtD
Bromazepam—GABRA3—central nervous system—Alzheimer's disease	0.00157	0.0096	CbGeAlD
Bromazepam—Anorexia—Galantamine—Alzheimer's disease	0.00157	0.0046	CcSEcCtD
Bromazepam—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00157	0.00459	CcSEcCtD
Bromazepam—Malnutrition—Donepezil—Alzheimer's disease	0.00157	0.00458	CcSEcCtD
Bromazepam—Hypotension—Galantamine—Alzheimer's disease	0.00154	0.00451	CcSEcCtD
Bromazepam—Tension—Donepezil—Alzheimer's disease	0.00154	0.0045	CcSEcCtD
Bromazepam—GABRA4—central nervous system—Alzheimer's disease	0.00153	0.00935	CbGeAlD
Bromazepam—Eye disorder—Memantine—Alzheimer's disease	0.00153	0.00447	CcSEcCtD
Bromazepam—Nervousness—Donepezil—Alzheimer's disease	0.00152	0.00445	CcSEcCtD
Bromazepam—Cardiac disorder—Memantine—Alzheimer's disease	0.00151	0.00444	CcSEcCtD
Bromazepam—Muscle spasms—Donepezil—Alzheimer's disease	0.0015	0.00441	CcSEcCtD
Bromazepam—GABRA4—cerebellum—Alzheimer's disease	0.0015	0.00914	CbGeAlD
Bromazepam—Eye disorder—Rivastigmine—Alzheimer's disease	0.00149	0.00437	CcSEcCtD
Bromazepam—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00148	0.00434	CcSEcCtD
Bromazepam—Vision blurred—Donepezil—Alzheimer's disease	0.00147	0.00432	CcSEcCtD
Bromazepam—Tremor—Donepezil—Alzheimer's disease	0.00147	0.00429	CcSEcCtD
Bromazepam—Somnolence—Galantamine—Alzheimer's disease	0.00147	0.00429	CcSEcCtD
Bromazepam—Dyspepsia—Galantamine—Alzheimer's disease	0.00145	0.00425	CcSEcCtD
Bromazepam—GABRD—brain—Alzheimer's disease	0.00144	0.00882	CbGeAlD
Bromazepam—Agitation—Donepezil—Alzheimer's disease	0.00144	0.00421	CcSEcCtD
Bromazepam—Decreased appetite—Galantamine—Alzheimer's disease	0.00143	0.00419	CcSEcCtD
Bromazepam—Mental disorder—Memantine—Alzheimer's disease	0.00143	0.00419	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00142	0.00417	CcSEcCtD
Bromazepam—Malnutrition—Memantine—Alzheimer's disease	0.00142	0.00416	CcSEcCtD
Bromazepam—Fatigue—Galantamine—Alzheimer's disease	0.00142	0.00416	CcSEcCtD
Bromazepam—Mental disorder—Rivastigmine—Alzheimer's disease	0.0014	0.0041	CcSEcCtD
Bromazepam—Tension—Memantine—Alzheimer's disease	0.00139	0.00408	CcSEcCtD
Bromazepam—Malnutrition—Rivastigmine—Alzheimer's disease	0.00139	0.00407	CcSEcCtD
Bromazepam—GABRG1—brain—Alzheimer's disease	0.00139	0.00849	CbGeAlD
Bromazepam—GABRA6—brain—Alzheimer's disease	0.00138	0.00844	CbGeAlD
Bromazepam—Nervousness—Memantine—Alzheimer's disease	0.00138	0.00404	CcSEcCtD
Bromazepam—Tension—Rivastigmine—Alzheimer's disease	0.00136	0.00399	CcSEcCtD
Bromazepam—Feeling abnormal—Galantamine—Alzheimer's disease	0.00136	0.00398	CcSEcCtD
Bromazepam—Convulsion—Donepezil—Alzheimer's disease	0.00136	0.00397	CcSEcCtD
Bromazepam—Nervousness—Rivastigmine—Alzheimer's disease	0.00135	0.00395	CcSEcCtD
Bromazepam—GABRB1—brain—Alzheimer's disease	0.00135	0.00823	CbGeAlD
Bromazepam—GABRA5—brain—Alzheimer's disease	0.00134	0.00819	CbGeAlD
Bromazepam—Vision blurred—Memantine—Alzheimer's disease	0.00134	0.00392	CcSEcCtD
Bromazepam—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00134	0.00391	CcSEcCtD
Bromazepam—Tremor—Memantine—Alzheimer's disease	0.00133	0.0039	CcSEcCtD
Bromazepam—GABRG2—nervous system—Alzheimer's disease	0.00133	0.00813	CbGeAlD
Bromazepam—GABRB2—nervous system—Alzheimer's disease	0.00133	0.00813	CbGeAlD
Bromazepam—Vision blurred—Rivastigmine—Alzheimer's disease	0.00131	0.00384	CcSEcCtD
Bromazepam—Agitation—Memantine—Alzheimer's disease	0.00131	0.00382	CcSEcCtD
Bromazepam—Dry mouth—Donepezil—Alzheimer's disease	0.0013	0.00382	CcSEcCtD
Bromazepam—Tremor—Rivastigmine—Alzheimer's disease	0.0013	0.00381	CcSEcCtD
Bromazepam—Confusional state—Donepezil—Alzheimer's disease	0.00129	0.00377	CcSEcCtD
Bromazepam—GABRB2—central nervous system—Alzheimer's disease	0.00128	0.00782	CbGeAlD
Bromazepam—GABRG2—central nervous system—Alzheimer's disease	0.00128	0.00782	CbGeAlD
Bromazepam—Agitation—Rivastigmine—Alzheimer's disease	0.00128	0.00374	CcSEcCtD
Bromazepam—Palpitations—Memantine—Alzheimer's disease	0.00126	0.00368	CcSEcCtD
Bromazepam—Nervous system disorder—Donepezil—Alzheimer's disease	0.00125	0.00367	CcSEcCtD
Bromazepam—GABRG2—cerebellum—Alzheimer's disease	0.00125	0.00765	CbGeAlD
Bromazepam—GABRB2—cerebellum—Alzheimer's disease	0.00125	0.00765	CbGeAlD
Bromazepam—GABRA3—brain—Alzheimer's disease	0.00125	0.00762	CbGeAlD
Bromazepam—Convulsion—Memantine—Alzheimer's disease	0.00123	0.0036	CcSEcCtD
Bromazepam—Palpitations—Rivastigmine—Alzheimer's disease	0.00123	0.0036	CcSEcCtD
Bromazepam—Anorexia—Donepezil—Alzheimer's disease	0.00122	0.00356	CcSEcCtD
Bromazepam—GABRA4—brain—Alzheimer's disease	0.00122	0.00743	CbGeAlD
Bromazepam—GABRA2—nervous system—Alzheimer's disease	0.00122	0.00742	CbGeAlD
Bromazepam—Hypersensitivity—Galantamine—Alzheimer's disease	0.00121	0.00356	CcSEcCtD
Bromazepam—GABRE—nervous system—Alzheimer's disease	0.00121	0.00736	CbGeAlD
Bromazepam—Convulsion—Rivastigmine—Alzheimer's disease	0.0012	0.00353	CcSEcCtD
Bromazepam—Hypotension—Donepezil—Alzheimer's disease	0.00119	0.00349	CcSEcCtD
Bromazepam—Dry mouth—Memantine—Alzheimer's disease	0.00118	0.00346	CcSEcCtD
Bromazepam—Asthenia—Galantamine—Alzheimer's disease	0.00118	0.00346	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00118	0.00344	CcSEcCtD
Bromazepam—GABRA1—nervous system—Alzheimer's disease	0.00118	0.00718	CbGeAlD
Bromazepam—GABRA2—central nervous system—Alzheimer's disease	0.00117	0.00715	CbGeAlD
Bromazepam—Confusional state—Memantine—Alzheimer's disease	0.00117	0.00342	CcSEcCtD
Bromazepam—GABRE—central nervous system—Alzheimer's disease	0.00116	0.00709	CbGeAlD
Bromazepam—Dry mouth—Rivastigmine—Alzheimer's disease	0.00116	0.00339	CcSEcCtD
Bromazepam—GABRA2—cerebellum—Alzheimer's disease	0.00114	0.00699	CbGeAlD
Bromazepam—Confusional state—Rivastigmine—Alzheimer's disease	0.00114	0.00335	CcSEcCtD
Bromazepam—Nervous system disorder—Memantine—Alzheimer's disease	0.00114	0.00333	CcSEcCtD
Bromazepam—Somnolence—Donepezil—Alzheimer's disease	0.00114	0.00332	CcSEcCtD
Bromazepam—Tachycardia—Memantine—Alzheimer's disease	0.00113	0.00331	CcSEcCtD
Bromazepam—GABRA1—central nervous system—Alzheimer's disease	0.00113	0.00691	CbGeAlD
Bromazepam—Skin disorder—Memantine—Alzheimer's disease	0.00113	0.0033	CcSEcCtD
Bromazepam—Dyspepsia—Donepezil—Alzheimer's disease	0.00112	0.00329	CcSEcCtD
Bromazepam—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00111	0.00326	CcSEcCtD
Bromazepam—Decreased appetite—Donepezil—Alzheimer's disease	0.00111	0.00325	CcSEcCtD
Bromazepam—Tachycardia—Rivastigmine—Alzheimer's disease	0.00111	0.00324	CcSEcCtD
Bromazepam—GABRA1—cerebellum—Alzheimer's disease	0.00111	0.00675	CbGeAlD
Bromazepam—Anorexia—Memantine—Alzheimer's disease	0.00111	0.00324	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0011	0.00323	CcSEcCtD
Bromazepam—Skin disorder—Rivastigmine—Alzheimer's disease	0.0011	0.00323	CcSEcCtD
Bromazepam—CYP2E1—telencephalon—Alzheimer's disease	0.0011	0.00673	CbGeAlD
Bromazepam—Fatigue—Donepezil—Alzheimer's disease	0.0011	0.00322	CcSEcCtD
Bromazepam—Dizziness—Galantamine—Alzheimer's disease	0.00109	0.00319	CcSEcCtD
Bromazepam—Hypotension—Memantine—Alzheimer's disease	0.00108	0.00317	CcSEcCtD
Bromazepam—Anorexia—Rivastigmine—Alzheimer's disease	0.00108	0.00317	CcSEcCtD
Bromazepam—Hypotension—Rivastigmine—Alzheimer's disease	0.00106	0.0031	CcSEcCtD
Bromazepam—Feeling abnormal—Donepezil—Alzheimer's disease	0.00105	0.00308	CcSEcCtD
Bromazepam—Vomiting—Galantamine—Alzheimer's disease	0.00105	0.00307	CcSEcCtD
Bromazepam—Rash—Galantamine—Alzheimer's disease	0.00104	0.00304	CcSEcCtD
Bromazepam—Dermatitis—Galantamine—Alzheimer's disease	0.00104	0.00304	CcSEcCtD
Bromazepam—Headache—Galantamine—Alzheimer's disease	0.00103	0.00302	CcSEcCtD
Bromazepam—Somnolence—Memantine—Alzheimer's disease	0.00103	0.00302	CcSEcCtD
Bromazepam—GABRB3—nervous system—Alzheimer's disease	0.00102	0.00624	CbGeAlD
Bromazepam—Dyspepsia—Memantine—Alzheimer's disease	0.00102	0.00299	CcSEcCtD
Bromazepam—GABRB2—brain—Alzheimer's disease	0.00102	0.00621	CbGeAlD
Bromazepam—GABRG2—brain—Alzheimer's disease	0.00102	0.00621	CbGeAlD
Bromazepam—Somnolence—Rivastigmine—Alzheimer's disease	0.00101	0.00295	CcSEcCtD
Bromazepam—Decreased appetite—Memantine—Alzheimer's disease	0.00101	0.00295	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.001	0.00293	CcSEcCtD
Bromazepam—Fatigue—Memantine—Alzheimer's disease	0.001	0.00293	CcSEcCtD
Bromazepam—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000999	0.00292	CcSEcCtD
Bromazepam—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000986	0.00289	CcSEcCtD
Bromazepam—GABRB3—central nervous system—Alzheimer's disease	0.000984	0.00601	CbGeAlD
Bromazepam—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00098	0.00287	CcSEcCtD
Bromazepam—Nausea—Galantamine—Alzheimer's disease	0.000979	0.00287	CcSEcCtD
Bromazepam—Fatigue—Rivastigmine—Alzheimer's disease	0.000978	0.00286	CcSEcCtD
Bromazepam—GABRB3—cerebellum—Alzheimer's disease	0.000962	0.00587	CbGeAlD
Bromazepam—Feeling abnormal—Memantine—Alzheimer's disease	0.000956	0.0028	CcSEcCtD
Bromazepam—Hypersensitivity—Donepezil—Alzheimer's disease	0.000941	0.00276	CcSEcCtD
Bromazepam—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000935	0.00274	CcSEcCtD
Bromazepam—GABRA2—brain—Alzheimer's disease	0.00093	0.00568	CbGeAlD
Bromazepam—GABRE—brain—Alzheimer's disease	0.000922	0.00563	CbGeAlD
Bromazepam—Asthenia—Donepezil—Alzheimer's disease	0.000916	0.00268	CcSEcCtD
Bromazepam—Pruritus—Donepezil—Alzheimer's disease	0.000904	0.00265	CcSEcCtD
Bromazepam—GABRA1—brain—Alzheimer's disease	0.000898	0.00548	CbGeAlD
Bromazepam—Hypersensitivity—Memantine—Alzheimer's disease	0.000854	0.0025	CcSEcCtD
Bromazepam—Dizziness—Donepezil—Alzheimer's disease	0.000845	0.00247	CcSEcCtD
Bromazepam—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000836	0.00245	CcSEcCtD
Bromazepam—Asthenia—Memantine—Alzheimer's disease	0.000832	0.00244	CcSEcCtD
Bromazepam—Pruritus—Memantine—Alzheimer's disease	0.000821	0.0024	CcSEcCtD
Bromazepam—Asthenia—Rivastigmine—Alzheimer's disease	0.000814	0.00238	CcSEcCtD
Bromazepam—Vomiting—Donepezil—Alzheimer's disease	0.000812	0.00238	CcSEcCtD
Bromazepam—Rash—Donepezil—Alzheimer's disease	0.000805	0.00236	CcSEcCtD
Bromazepam—Dermatitis—Donepezil—Alzheimer's disease	0.000805	0.00236	CcSEcCtD
Bromazepam—Pruritus—Rivastigmine—Alzheimer's disease	0.000803	0.00235	CcSEcCtD
Bromazepam—Headache—Donepezil—Alzheimer's disease	0.0008	0.00234	CcSEcCtD
Bromazepam—GABRB3—brain—Alzheimer's disease	0.000781	0.00477	CbGeAlD
Bromazepam—Dizziness—Memantine—Alzheimer's disease	0.000767	0.00225	CcSEcCtD
Bromazepam—Nausea—Donepezil—Alzheimer's disease	0.000759	0.00222	CcSEcCtD
Bromazepam—Dizziness—Rivastigmine—Alzheimer's disease	0.00075	0.0022	CcSEcCtD
Bromazepam—Vomiting—Memantine—Alzheimer's disease	0.000737	0.00216	CcSEcCtD
Bromazepam—Rash—Memantine—Alzheimer's disease	0.000731	0.00214	CcSEcCtD
Bromazepam—Dermatitis—Memantine—Alzheimer's disease	0.000731	0.00214	CcSEcCtD
Bromazepam—Headache—Memantine—Alzheimer's disease	0.000727	0.00213	CcSEcCtD
Bromazepam—Vomiting—Rivastigmine—Alzheimer's disease	0.000721	0.00211	CcSEcCtD
Bromazepam—Rash—Rivastigmine—Alzheimer's disease	0.000715	0.00209	CcSEcCtD
Bromazepam—Dermatitis—Rivastigmine—Alzheimer's disease	0.000715	0.00209	CcSEcCtD
Bromazepam—Headache—Rivastigmine—Alzheimer's disease	0.000711	0.00208	CcSEcCtD
Bromazepam—Nausea—Memantine—Alzheimer's disease	0.000689	0.00202	CcSEcCtD
Bromazepam—Nausea—Rivastigmine—Alzheimer's disease	0.000674	0.00197	CcSEcCtD
Bromazepam—CYP2E1—nervous system—Alzheimer's disease	0.00065	0.00397	CbGeAlD
Bromazepam—CYP2E1—central nervous system—Alzheimer's disease	0.000626	0.00382	CbGeAlD
Bromazepam—CYP2E1—cerebellum—Alzheimer's disease	0.000612	0.00374	CbGeAlD
Bromazepam—CYP3A4—nervous system—Alzheimer's disease	0.000523	0.00319	CbGeAlD
Bromazepam—CYP3A4—central nervous system—Alzheimer's disease	0.000504	0.00308	CbGeAlD
Bromazepam—CYP2E1—brain—Alzheimer's disease	0.000497	0.00303	CbGeAlD
Bromazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	9.14e-05	0.00042	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	9.12e-05	0.00042	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—CALM1—Alzheimer's disease	9.12e-05	0.000419	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—TF—Alzheimer's disease	9.11e-05	0.000419	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—PRKCG—Alzheimer's disease	9.08e-05	0.000418	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—CP—Alzheimer's disease	9.07e-05	0.000417	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—CP—Alzheimer's disease	9.01e-05	0.000414	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—CALM1—Alzheimer's disease	9e-05	0.000414	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.99e-05	0.000414	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	8.97e-05	0.000413	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.94e-05	0.000411	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—PRKCG—Alzheimer's disease	8.92e-05	0.00041	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	8.87e-05	0.000408	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—PRKCG—Alzheimer's disease	8.86e-05	0.000408	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—CP—Alzheimer's disease	8.85e-05	0.000407	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	8.8e-05	0.000405	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.78e-05	0.000404	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—PRKCG—Alzheimer's disease	8.7e-05	0.0004	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	8.7e-05	0.0004	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.7e-05	0.0004	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.62e-05	0.000397	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	8.59e-05	0.000395	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.58e-05	0.000395	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.57e-05	0.000394	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.41e-05	0.000387	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—CREB1—Alzheimer's disease	8.37e-05	0.000385	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.3e-05	0.000382	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.3e-05	0.000382	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—CASP3—Alzheimer's disease	8.25e-05	0.000379	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—CREB1—Alzheimer's disease	8.25e-05	0.000379	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—CALM1—Alzheimer's disease	8.23e-05	0.000379	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.23e-05	0.000378	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	8.17e-05	0.000376	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—CALM1—Alzheimer's disease	8e-05	0.000368	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.99e-05	0.000368	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—CALM1—Alzheimer's disease	7.85e-05	0.000361	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.85e-05	0.000361	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—CREB1—Alzheimer's disease	7.8e-05	0.000359	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—CP—Alzheimer's disease	7.73e-05	0.000356	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—CALM1—Alzheimer's disease	7.72e-05	0.000355	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.71e-05	0.000355	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—CREB1—Alzheimer's disease	7.71e-05	0.000354	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—CALM1—Alzheimer's disease	7.67e-05	0.000353	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.66e-05	0.000352	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	7.61e-05	0.00035	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—PRKCG—Alzheimer's disease	7.61e-05	0.00035	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—MAPK8—Alzheimer's disease	7.58e-05	0.000349	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	7.54e-05	0.000347	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—CALM1—Alzheimer's disease	7.53e-05	0.000346	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TF—Alzheimer's disease	7.52e-05	0.000346	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	7.35e-05	0.000338	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	7.12e-05	0.000327	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	7.08e-05	0.000326	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—CREB1—Alzheimer's disease	7.05e-05	0.000324	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	7.04e-05	0.000324	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	6.91e-05	0.000318	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—CREB1—Alzheimer's disease	6.85e-05	0.000315	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.84e-05	0.000314	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	6.78e-05	0.000312	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.73e-05	0.00031	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—CREB1—Alzheimer's disease	6.72e-05	0.000309	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	6.69e-05	0.000308	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	6.66e-05	0.000306	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	6.64e-05	0.000305	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—CREB1—Alzheimer's disease	6.61e-05	0.000304	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—CALM1—Alzheimer's disease	6.58e-05	0.000303	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TF—Alzheimer's disease	6.58e-05	0.000302	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—CREB1—Alzheimer's disease	6.56e-05	0.000302	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—DHCR24—Alzheimer's disease	6.52e-05	0.0003	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—CREB1—Alzheimer's disease	6.45e-05	0.000296	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.37e-05	0.000293	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	6.36e-05	0.000293	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.29e-05	0.000289	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	5.99e-05	0.000276	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	5.87e-05	0.00027	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.75e-05	0.000265	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	5.64e-05	0.000259	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—CREB1—Alzheimer's disease	5.63e-05	0.000259	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.59e-05	0.000257	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CA4—Alzheimer's disease	5.54e-05	0.000255	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	5.5e-05	0.000253	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.49e-05	0.000252	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.39e-05	0.000248	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.36e-05	0.000246	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	5.34e-05	0.000245	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	5.26e-05	0.000242	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	5.23e-05	0.000241	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GAPDHS—Alzheimer's disease	5.21e-05	0.00024	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.16e-05	0.000237	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	5.14e-05	0.000236	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	5.14e-05	0.000236	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	5.03e-05	0.000231	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ATP5A1—Alzheimer's disease	4.94e-05	0.000227	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	4.83e-05	0.000222	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLD3—Alzheimer's disease	4.71e-05	0.000217	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.69e-05	0.000216	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.6e-05	0.000212	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	4.52e-05	0.000208	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—AKT1—Alzheimer's disease	4.47e-05	0.000205	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	4.35e-05	0.0002	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CA4—Alzheimer's disease	4.28e-05	0.000197	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ND1—Alzheimer's disease	4.2e-05	0.000193	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.18e-05	0.000192	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	4.02e-05	0.000185	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	3.92e-05	0.00018	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.9e-05	0.000179	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	3.81e-05	0.000175	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.65e-05	0.000168	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLD3—Alzheimer's disease	3.64e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.64e-05	0.000167	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.59e-05	0.000165	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	3.49e-05	0.00016	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.41e-05	0.000157	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	3.36e-05	0.000154	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CA4—Alzheimer's disease	3.33e-05	0.000153	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.26e-05	0.00015	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ND1—Alzheimer's disease	3.24e-05	0.000149	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.17e-05	0.000146	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	3.13e-05	0.000144	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.02e-05	0.000139	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	2.97e-05	0.000137	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.9e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLD3—Alzheimer's disease	2.83e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.83e-05	0.00013	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.8e-05	0.000129	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	2.72e-05	0.000125	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CHAT—Alzheimer's disease	2.71e-05	0.000125	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TPI1—Alzheimer's disease	2.71e-05	0.000125	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.66e-05	0.000122	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	2.61e-05	0.00012	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MAOB—Alzheimer's disease	2.6e-05	0.000119	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.57e-05	0.000118	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ND1—Alzheimer's disease	2.53e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	2.5e-05	0.000115	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.5e-05	0.000115	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.47e-05	0.000114	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.42e-05	0.000111	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—A2M—Alzheimer's disease	2.41e-05	0.000111	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.29e-05	0.000105	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.27e-05	0.000105	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.26e-05	0.000104	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.19e-05	0.000101	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ACHE—Alzheimer's disease	2.1e-05	9.65e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.1e-05	9.64e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CHAT—Alzheimer's disease	2.09e-05	9.61e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TPI1—Alzheimer's disease	2.09e-05	9.61e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	2.07e-05	9.54e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.02e-05	9.28e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MAOB—Alzheimer's disease	2e-05	9.21e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ENO1—Alzheimer's disease	1.97e-05	9.05e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	1.97e-05	9.05e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.95e-05	8.96e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.95e-05	8.95e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	1.93e-05	8.87e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.93e-05	8.86e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.91e-05	8.76e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.89e-05	8.68e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.86e-05	8.56e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—BCHE—Alzheimer's disease	1.83e-05	8.41e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.77e-05	8.15e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	1.73e-05	7.94e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	1.67e-05	7.69e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.66e-05	7.63e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.63e-05	7.48e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.63e-05	7.48e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.62e-05	7.45e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.6e-05	7.36e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.56e-05	7.18e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.52e-05	6.98e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.52e-05	6.98e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.5e-05	6.91e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.49e-05	6.84e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.48e-05	6.83e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.47e-05	6.77e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.45e-05	6.67e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	1.44e-05	6.63e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	1.43e-05	6.6e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.41e-05	6.49e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.33e-05	6.12e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—LPL—Alzheimer's disease	1.31e-05	6.04e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.31e-05	6.01e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.29e-05	5.95e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.29e-05	5.93e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ACHE—Alzheimer's disease	1.26e-05	5.8e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.26e-05	5.78e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.26e-05	5.78e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	1.25e-05	5.74e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.2e-05	5.54e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	1.18e-05	5.44e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ENO1—Alzheimer's disease	1.18e-05	5.44e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	1.18e-05	5.43e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	1.16e-05	5.33e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.16e-05	5.33e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.12e-05	5.15e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.11e-05	5.11e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.11e-05	5.09e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CALM1—Alzheimer's disease	1.1e-05	5.08e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—APOE—Alzheimer's disease	1.1e-05	5.06e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—BCHE—Alzheimer's disease	1.1e-05	5.06e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CAV1—Alzheimer's disease	1.09e-05	5.01e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	1.04e-05	4.77e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.02e-05	4.68e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.01e-05	4.66e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.01e-05	4.62e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.74e-06	4.48e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.63e-06	4.43e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PPARG—Alzheimer's disease	9.58e-06	4.41e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—INS—Alzheimer's disease	9.4e-06	4.32e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ENO1—Alzheimer's disease	9.13e-06	4.2e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	9.13e-06	4.2e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	9.12e-06	4.19e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.95e-06	4.12e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	8.67e-06	3.99e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	8.63e-06	3.97e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CALM1—Alzheimer's disease	8.52e-06	3.92e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—APOE—Alzheimer's disease	8.49e-06	3.9e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.48e-06	3.9e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CAV1—Alzheimer's disease	8.41e-06	3.87e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NOS3—Alzheimer's disease	8.24e-06	3.79e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	8.01e-06	3.68e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—LPL—Alzheimer's disease	7.89e-06	3.63e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.76e-06	3.57e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	7.54e-06	3.47e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PPARG—Alzheimer's disease	7.39e-06	3.4e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—INS—Alzheimer's disease	7.25e-06	3.33e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	7.1e-06	3.27e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.69e-06	3.08e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.66e-06	3.06e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CALM1—Alzheimer's disease	6.64e-06	3.05e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—APOE—Alzheimer's disease	6.61e-06	3.04e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CAV1—Alzheimer's disease	6.55e-06	3.01e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NOS3—Alzheimer's disease	6.36e-06	2.92e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—LPL—Alzheimer's disease	6.09e-06	2.8e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	5.82e-06	2.67e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PPARG—Alzheimer's disease	5.76e-06	2.65e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—INS—Alzheimer's disease	5.65e-06	2.6e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.48e-06	2.52e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.12e-06	2.36e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—APOE—Alzheimer's disease	5.1e-06	2.35e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CAV1—Alzheimer's disease	5.06e-06	2.33e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—NOS3—Alzheimer's disease	4.95e-06	2.28e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	4.53e-06	2.08e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.45e-06	2.04e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—INS—Alzheimer's disease	4.36e-06	2.01e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.82e-06	1.76e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—AKT1—Alzheimer's disease	3.79e-06	1.74e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.5e-06	1.61e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—AKT1—Alzheimer's disease	2.92e-06	1.34e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—AKT1—Alzheimer's disease	2.28e-06	1.05e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.76e-06	8.08e-06	CbGpPWpGaD
